Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Gako-hitzak:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideLaburpena
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Deskargak
Argitaratua
2021-02-05
Zenbakia
Atala
Review Article
Lizentzia
Egile-eskubideak 2021 Muhammad Umair Afzal, Shafeeq Cheema
Lan hau Creative Commons Aitortu-EzKomertziala 4.0 Nazioarteko Lizentziapean dago argitaratuta.
Aipuak nola egin
Phosphate Binders in CKD: ‟New Kids on the Block”. (2021). Pakistan Journal of Kidney Diseases, 3(10). https://doi.org/10.53778/pjkd31089
